Literature DB >> 9530110

Ontogeny of malate-aspartate shuttle capacity and gene expression in cardiac mitochondria.

T D Scholz1, S L Koppenhafer, C J tenEyck, B C Schutte.   

Abstract

Developmental downregulation of the malate-aspartate shuttle has been observed in cardiac mitochondria. The goals of this study were to determine the time course of the postnatal decline and to identify potential regulatory sites by measuring steady-state myocardial mRNA and protein levels of the mitochondrial proteins involved in the shuttle. By use of isolated porcine cardiac mitochondria incubated with saturating concentrations of the cytosolic components of the malate-aspartate shuttle, shuttle capacity was found to decline by approximately 50% during the first 5 wk of life (from 921 +/- 48 to 531 +/- 53 nmol.min-1.mg protein-1). Mitochondrial aspartate aminotransferase mRNA levels were greater in adult than in newborn myocardium. mRNA levels of mitochondrial malate dehydrogenase in adult cardiac tissue were 224% of levels in newborn tissue, whereas protein levels were 54% greater in adult myocardium. Aspartate/glutamate carrier protein levels were also greater in adult than in newborn tissue. mRNA and protein levels of the oxoglutarate/malate carrier were increased in newborn myocardium. It was concluded that 1) myocardial malate-aspartate shuttle capacity declines rapidly after birth, 2) divergence of mitochondrial malate dehydrogenase mRNA and protein levels during development suggests posttranscriptional regulation of this protein, and 3) the developmental decline in malate-aspartate shuttle capacity is regulated by decreased oxoglutarate/malate carrier gene expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9530110     DOI: 10.1152/ajpcell.1998.274.3.C780

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Authors:  Dan Shao; Rong Tian
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

Review 2.  Return to the fetal gene program: a suggested metabolic link to gene expression in the heart.

Authors:  Heinrich Taegtmeyer; Shiraj Sen; Deborah Vela
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 3.  The mitochondrial aspartate/glutamate carrier AGC1 and calcium homeostasis: physiological links and abnormalities in autism.

Authors:  Valerio Napolioni; Antonio M Persico; Vito Porcelli; Luigi Palmieri
Journal:  Mol Neurobiol       Date:  2011-06-21       Impact factor: 5.590

Review 4.  Glucose metabolism and cardiac hypertrophy.

Authors:  Stephen C Kolwicz; Rong Tian
Journal:  Cardiovasc Res       Date:  2011-05-01       Impact factor: 10.787

5.  Superior cardiac function via anaplerotic pyruvate in the immature swine heart after cardiopulmonary bypass and reperfusion.

Authors:  Aaron K Olson; Outi M Hyyti; Gordon A Cohen; Xue-Han Ning; Martin Sadilek; Nancy Isern; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-10       Impact factor: 4.733

6.  Fetal programming alters reactive oxygen species production in sheep cardiac mitochondria.

Authors:  Nicholas H von Bergen; Stacia L Koppenhafer; Douglas R Spitz; Kenneth A Volk; Sonali S Patel; Robert D Roghair; Fred S Lamb; Jeffrey L Segar; Thomas D Scholz
Journal:  Clin Sci (Lond)       Date:  2009-04       Impact factor: 6.124

7.  Role of the malate-aspartate shuttle on the metabolic response to myocardial ischemia.

Authors:  Ming Lu; Lufang Zhou; William C Stanley; Marco E Cabrera; Gerald M Saidel; Xin Yu
Journal:  J Theor Biol       Date:  2008-07-07       Impact factor: 2.691

Review 8.  Return to the fetal gene program protects the stressed heart: a strong hypothesis.

Authors:  Mitra Rajabi; Christos Kassiotis; Peter Razeghi; Heinrich Taegtmeyer
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

9.  Respiration and substrate transport rates as well as reactive oxygen species production distinguish mitochondria from brain and liver.

Authors:  Aaron M Gusdon; Gabriel A Fernandez-Bueno; Stephanie Wohlgemuth; Jenelle Fernandez; Jing Chen; Clayton E Mathews
Journal:  BMC Biochem       Date:  2015-09-10       Impact factor: 4.059

10.  Endogenous sulfur dioxide is a novel adipocyte-derived inflammatory inhibitor.

Authors:  Heng Zhang; Yaqian Huang; Dingfang Bu; Selena Chen; Chaoshu Tang; Guang Wang; Junbao Du; Hongfang Jin
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.